Botswana vs Ireland: Antiretroviral therapy coverage for PMTCT
Botswana
100.0%
in 2024
Ireland
100.0%
in 2024
Botswana rank
1st
Ireland rank
1st
Antiretroviral therapy coverage for PMTCT over time
- Botswana
- Ireland
How they compare
Botswana currently reports 100.0% against 100.0% in Ireland, a difference of 0.0%.
Across all 19 years both countries report, Ireland has been ahead every year.
Botswana ranks 1st and Ireland ranks 1st of 84 countries.
Ireland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Botswana | Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 52.4% | 90.0% | 37.6% | Ireland |
| 2010s | 94.4% | 100.0% | 5.6% | Ireland |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Botswana or Ireland?
- Botswana, at 100.0% against 100.0% in Ireland as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Botswana and Ireland?
- 0.0%, with Botswana ahead.
- How many years of comparable data are there for Botswana and Ireland?
- 19 years are reported by both, from 2000 to 2024.
- How do Botswana and Ireland rank globally for antiretroviral therapy coverage for pmtct?
- Botswana ranks 1st and Ireland ranks 1st of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).